CYTO

Altamira Therapeutics Ltd.

2.42 USD
-0.01 (-0.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Altamira Therapeutics Ltd. stock is up 35.96% since 30 days ago. The next earnings date is May 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 March’s closed higher than February.

About Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets.